• Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial.
    • Recchia G, Lawrence ACE, Capacchione L, Freeman ALJ.
    • Genet Med. 2022 May 5:S1098-3600(22)00745-6. doi: 10.1016/j.gim.2022.04.016. Epub ahead of print.
  • LitAlert ~~ GeneLit.com

    • Understanding the Experience of Canadian Women Living with Ovarian Cancer through the Every Woman Study™
    • Tone A, Boghosian T, Ross A, Baugh E, Altman AD, Dawson L, Reid F, Crawford C.
    • Curr Oncol. 2022 May 5;29(5):3318-3340. doi: 10.3390/curroncol29050271.
    • Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: a prospective study.
    • Brédart A, De Pauw A, Tüchler A, Lakeman IMM, Anota A, Rhiem K, Schmutzler R, van Asperen CJ, Devilee P, Stoppa-Lyonnet D, Kop JL, Dolbeault S.
    • Clin Genet. 2022 May 4. doi: 10.1111/cge.14147. Epub ahead of print.
  • LitAlert ~~ GeneLit.com

    • Effects of diet education on empowerment for individuals who have an increased risk of developing breast or colon cancer: A pilot study.
    • Tlusty K, Jackson M, Riley B, Blase T.
    • J Genet Couns. 2022 May 3. doi: 10.1002/jgc4.1584. Epub ahead of print.
    • African American Women Need to Know More About High-Risk Breast Cancer.
    • Johnson F.
    • FORCE. Blog. 2022 May 2.
    • Perceptions and Care Recommendations from Previvors: Qualitative Analysis of Female BRCA1/2 Mutation Carriers’ Experience with Genetic Testing and Counseling.
    • Dibble KE, Donorfio LKM, Britner PA, Bellizzi KM.
    • Gynecol Oncol Rep. 2022 May 2;100989. doi: 10.1016/j.gore.2022.100989.
  • LitAlert ~~ GeneLit.com

    • Volunteer Spotlight – Mike Philbin.
    • [No author given]
    • FORCE. Blog. 2022 Apr 29.
    • Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.
    • Hardy MW, Peshkin BN, Rose E, Ladd MK, Binion S, Tynan M, McBride CM, Grinzaid KA, Schwartz MD.
    • J Community Genet. 2022 Apr 29. doi: 10.1007/s12687-022-00590-3. Epub ahead of print.
    • Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
    • Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Sanderson S, Waller J, Ahmed M, Wallace A, Wallis Y, Menon U, Jacobs I, Legood R, Marks D, Manchanda R.
    • Diagnostics (Basel). 2022 Apr 19;12(5):1028. doi: 10.3390/diagnostics12051028.
  • LitAlert ~~ GeneLit.com

    • Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
    • McCuaig JM, Ferguson SE, Vicus D, Ott K, Stockley TL, Kim RH, Metcalfe KA.
    • Hered Cancer Clin Pract. 2022 Apr 13;20(1):15. doi: 10.1186/s13053-022-00221-5.
    • Preimplantation genetic testing in patients with genetic susceptibility to cancer.
    • Villy MC, Frydman N, Moutou C, Thierry G, Raad J, Colas C, Steffann J, Metras J, Chabbert-Buffet N, Parc Y, Richard S, Benusiglio PR.
    • Fam Cancer. 2022 Apr 12. doi: 10.1007/s10689-022-00293-1. Epub ahead of print.
    • Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community.
    • Scheuner MT, Huynh AK, Chanfreau-Coffinier C, Lerner B, Gable AR, Lee M, Simon A, Coeshott R, Hamilton AB, Patterson OV, DuVall S, Russell MM.
    • JAMA Netw Open. 2022 Apr 1;5(4):e226687. doi: 10.1001/jamanetworkopen.2022.6687.
  • LitAlert ~~ GeneLit.com

    • Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.
    • Brédart A, Kop JL, Tüchler A, De Pauw A, Cano A, Dick J, Rhiem K, Devilee P, Schmutzler R, Stoppa-Lyonnet D, Dolbeault S.
    • Eur J Hum Genet. 2022 Apr 11. doi: 10.1038/s41431-022-01096-9. Epub ahead of print.
    • A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
    • Petrocchi S, Ongaro G, Calvello M, Feroce I, Bonanni B, Pravettoni G.
    • PLoS One. 2022 Apr 8;17(4):e0266327. doi: 10.1371/journal.pone.0266327.